The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...

Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...

The diseases include dengue, chikungunya, zika and yellow fever among others. India experiences a large number of deaths due ...

The FDA and CDC recommended a pause in administering Ixchiq, a chikungunya vaccine, in adults ages 60 and above after 17 serious adverse events, including two deaths.  About 80,000 Ixchiq doses have ...

The FDA and CDC are investigating reports of serious adverse events, including deaths, in recipients of Ixchiq.

The decision follows ongoing investigations into serious adverse events primarily reported in elderly individuals who ...

U.S. health officials are telling travelers aged 60 and older to avoid a chikungunya vaccine while they investigate possible ...

The United States is advising travellers aged 60 and up to hold off on getting the chikungunya vaccine while it looks into reports of possible side effects.

A total of 19,901 dengue cases have been reported in the country so far this year, according to the National Dengue Control ...

Researchers say they've discovered an already approved migraine drug that can stop symptoms hours before a severe headache ...

Highlighting the pivotal role of VHSNCs in addressing public health concerns, the minister said that the committees would ...

Mosquitoes are highly visual hunters when it comes to finding a human to bite. This means movement and dark clothing colors ...